Galmed Pharmaceuticals (EOCN) Total Non-Current Liabilities (2013 - 2026)
Galmed Pharmaceuticals (EOCN) recorded Total Non-Current Liabilities of $2.73 million in Q2 2026.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
At the end of FY2024, Galmed Pharmaceuticals reported Total Non-Current Liabilities of $1.67 million, up 165.1% from FY2023.
- Annual Total Non-Current Liabilities has a five-year compound annual growth rate of 36.5% (FY2019 to FY2024).
- Across earlier years, Total Non-Current Liabilities came in at $628,000 in FY2023, $44,000 in FY2022 (-80.8%), $229,000 in FY2021 (+6.0%) and $216,000 in FY2020 (-38.6%).
- The Q2 2026 figure is the highest quarterly Total Non-Current Liabilities since Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Galmed Pharmaceuticals | 1.64 Mn | -39.05 Mn | - | 2.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.73 Mn |
| Dec 31, 2024 | 1.67 Mn |
| Dec 31, 2023 | 628,000.00 |
| Mar 31, 2023 | 5.06 Mn |
| Dec 31, 2022 | 44,000.00 |
| Sep 30, 2022 | 89,000.00 |
| Jun 30, 2022 | 134,000.00 |
| Mar 31, 2022 | 183,000.00 |
| Dec 31, 2021 | 229,000.00 |
| Sep 30, 2021 | 274,000.00 |
| Jun 30, 2021 | 318,000.00 |
| Mar 31, 2021 | 283,000.00 |
| Dec 31, 2020 | 216,000.00 |
| Sep 30, 2020 | 247,000.00 |
| Jun 30, 2020 | 251,000.00 |
| Mar 31, 2020 | 302,000.00 |
| Dec 31, 2019 | 352,000.00 |
| Sep 30, 2019 | 389,000.00 |
| Jun 30, 2019 | 442,000.00 |
| Mar 31, 2019 | 499,000.00 |
API Access
Galmed Pharmaceuticals Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();